BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Argus Health
AstraZeneca
McKesson
Federal Trade Commission
Baxter
Merck
US Army
Cantor Fitzgerald

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207044

« Back to Dashboard

NDA 207044 describes LEVONORGESTREL, which is a drug marketed by Wyeth Pharms Inc, Glenmark Pharms Ltd, Lotus Pharm Co Ltd, Lupin Ltd, Mylan Labs Ltd, Novel Labs Inc, Oc Pharma, Perrigo R And D, Reckitt Benckiser, Watson Labs, Watson Labs Inc, Amneal Pharms, Glenmark Generics, Mayne Pharma, and Barr, and is included in thirty-seven NDAs. It is available from fifteen suppliers. Additional details are available on the LEVONORGESTREL profile page.

The generic ingredient in LEVONORGESTREL is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 207044
Tradename:LEVONORGESTREL
Applicant:Glenmark Pharms Ltd
Ingredient:levonorgestrel
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 207044
Suppliers and Packaging for NDA: 207044
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVONORGESTREL levonorgestrel TABLET;ORAL 207044 ANDA Glenmark Pharmaceuticals Inc., USA 68462-123 68462-123-40 1 BLISTER PACK in 1 CARTON (68462-123-40) > 1 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Mar 25, 2016TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Citi
Johnson and Johnson
Deloitte
UBS
Healthtrust
McKinsey
Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot